Idiopathic pulmonary fibrosis (IPF) is a devastating disease with no cure available. Patients
suffer from respiratory symptoms including dyspnea and cough. To improve life quality the
investigators will test the effects of immunomodulation of macrolides specifically on cough
in IPF patients. The investigators hypothesize that immunomodulatory treatment reduces cough
frequency and might improve lung function.